Auto-Immune Diseases Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Summary
GlobalData's Medical Devices sector report, “Auto-Immune Diseases Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Auto-Immune Diseases pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Auto-Immune Diseases Diagnostic Tests are used for detection of autoimmune disorder by identifying auto-antibodies in the patient’s test sample.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Auto-Immune Diseases under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Auto-Immune Diseases and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Auto-Immune Diseases under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
About GlobalData
Introduction
Auto-Immune Diseases Overview
Products under Development
Auto-Immune Diseases - Pipeline Products by Stage of Development
Table Figure 1: Auto-Immune Diseases - Pipeline Products by Stage of Development
Table Auto-Immune Diseases - Pipeline Products by Stage of Development
Auto-Immune Diseases - Pipeline Products by Territory
Table Figure 2: Auto-Immune Diseases - Pipeline Products by Territory
Table Auto-Immune Diseases - Pipeline Products by Territory
Auto-Immune Diseases - Pipeline Products by Regulatory Path
Table Companion Diagnostic Assay - Ulcerative Colitis - A Phase 2, Multi-center, Double-blind, Placebo-controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Induction Therapy with PRA023 in Subjects with Moderately to Severely Active Ulcerative Colitis
Table PRA052 Companion Diagnostic Assay - A Phase I, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetics Study of PRA052 in Healthy Volunteers
Protagen AG Company Overview
Protagen AG Pipeline Products & Ongoing Clinical Trials Overview
Table Protagen AG Pipeline Products & Ongoing Clinical Trials Overview
Table Diagnostic Assay - Ankylosing Spondylitis - Product Status
Table Nu.Q H3.1 NETs Assay - Autoimmune Diseases - Observational Study of the Practical Cinical Utility of the NuQ. H3.1 Nucleosome Levels in Adult Patients With Sepsis to Facilitate Early Diagnosis and Prognostication. (EPICETUS)
Washington University in St Louis Company Overview
Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview
Table Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview
Table Biomarker Test - Multiple Sclerosis - Product Status(Washington University in St Louis)
Table Biomarker Test - Multiple Sclerosis - Product Description(Washington University in St Louis)
Dec 13, 2023: Thermo Fisher Scientific Signs Long-Term, Exclusive U.S. Distributor Agreement With Aesku.Group for IFA Testing Kits & Instruments
Dec 12, 2023: Genentech Announces Appointment of Ashley Magargee as Chief Executive Officer
Dec 05, 2023: Siemens Healthineers Appoints Vivek Kanade as New Head For Its Middle East and Africa Operations
Nov 30, 2023: Wilmot L. Matthews Announces Resignation as Director of SQI Diagnostics Debt Forgiveness, Voting Trust Agreement and Related Transactions
Nov 28, 2023: Quest Diagnostics and Scipher Medicine Collaborate to Scale Precision Medicine Access for Patients with Rheumatoid Arthritis
Nov 28, 2023: Thermo Fisher Scientific Prices Offering Of $2.5 Bln Of Senior Notes
Nov 09, 2023: Roche's MS test scores FDA breakthrough device designation
Nov 02, 2023: Immunovia Announces Invitation to Q3 Presentation
Nov 01, 2023: CareDx Announces CEO Transition
Oct 25, 2023: HSS Appoints New Leadership in Neurology and Anesthesia
Oct 18, 2023: Roche IL-6 Is the First Immunoassay Approved to Aid Sepsis Diagnosis in Newborns
Oct 11, 2023: Octave Bioscience Presents Data Highlighting Application and Impact of its Precision Care Solution at MSMilan2023
Oct 11, 2023: Theradiag Reports 20% Revenue Growth in Q3 2023
Oct 04, 2023: ROME Expands Leadership Team with the Appointment of Industry Veteran Kyle Kuvalanka as Chief Financial Officer and Chief Business Officer
Sep 01, 2023: Adaptive Biotechnologies Corp. Announces Kevin Conroy Resigns from the Board
Aug 30, 2023: Octave Bioscience, Announces Publication of Clinical Validation Study Results of Its Novel, Multivariate Multiple Sclerosis Disease Activity (MSDA) Blood Test
Aug 30, 2023: Immunovia Publishes Interim Report for January-June 2023
Aug 29, 2023: Co-Diagnostics Appoints Chief Regulatory Affairs Officer
Aug 28, 2023: Bio-Rad to Participate in Fireside Chat During Wells Fargo's 2023 Healthcare Conference
Aug 23, 2023: Immunovia Announces Invitation for Q2 Presentation
Aug 17, 2023: Myriad Genetics to Host Investor Day on September 19, 2023
Aug 14, 2023: Thermo Fisher Scientific to Trim Staff by More Than 200 at Florida Site
Jul 17, 2023: Theradiag Reports Revenue of €6.7 Million for the First Half of 2023, up 6.8%
Jul 05, 2023: Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 26, 2023
Jun 15, 2023: Immuno Concepts Receives 510(k) Clearance for IgG Anti-nDNA Fluorescent Test System
Jun 13, 2023: HSS Appoints Mary E. Cassai, RN to Executive Vice President, Chief Operating Officer
May 30, 2023: SQI Diagnostics reports second quarter 2023 results
May 22, 2023: Immunovia: Changes to the nomination committee's proposal to the annual general meeting 2023
May 09, 2023: Grifols delivers strong first quarter financials with 23% revenue growth and an adjusted EBITDA margin above guidance of 21%
May 08, 2023: CareDx to report first quarter 2023 financial results
May 05, 2023: Co-Diagnostics announces first quarter 2023 earnings release date and webcast
May 03, 2023: Adaptive Biotechnologies reports First Quarter 2023 financial results
May 03, 2023: Myriad Genetics reports first quarter 2023 financial results
Apr 25, 2023: OPKO Health to report Q1 2023 financial results on May 3, 2023
Apr 21, 2023: Immunovia announces annual report for 2022
Apr 20, 2023: QIAGEN announces expansion of supervisory board
Mar 16, 2023: Immunovia Announces Bulletin from the extraordinary general meeting
Mar 13, 2023: Provention Bio Cancels Fourth Quarter and Full Year 2022 Earnings Release and Conference Call
Mar 09, 2023: Co-diagnostics Announces Fourth Quarter and Full Year 2022 Earnings Release Date and Webcast
Mar 08, 2023: UCSF Health Appoints Two Prominent Healthcare Executives to Senior Leadership Positions
Mar 03, 2023: Grifols Announces Full Year 2022 Earnings
Mar 01, 2023: Immunovia appoints Karl Stone as new chief operating officer to develop R&D and operations
Feb 25, 2023: Octave presents data from nine company and partner abstracts at ACTRIMS Forum 2023
Feb 23, 2023: Immunovia Publishes Full Year Report for 2022
Feb 22, 2023: Prometheus Biosciences announces two oral presentations on PRA023 at the 18th Congress of European Crohn's and Colitis Organisation (ECCO)
Feb 22, 2023: Thomas Glanzmann new Grifols Executive Chairman, after Steven F. Mayer resignation
Feb 21, 2023: CareDx to Report Fourth Quarter and Full Year 2022 Financial Results
Feb 20, 2023: Immunovia Notice of Extraordinary General Meeting
Feb 20, 2023: Immunovia's Invitation to Q4 presentation
Feb 16, 2023: OPKO Health to Report Fourth Quarter 2022 Financial Results on February 23, 2023
Feb 15, 2023: World Leader In Musculoskeletal Health HSS Announces Douglas E. Padgett, MD to become Next Surgeon-in-Chief and Medical Director
Feb 14, 2023: Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2022 Financial Results
Feb 07, 2023: QIAGEN Exceeds Outlook for Fourth Quarter and Full-Year 2022 With 14% CER Sales Growth in FY 2022 From Non-COVID Product Groups
Feb 06, 2023: Hospital for Special Surgery Announces Rightmove Appoints Marcus Osborne As Ceo
Jan 27, 2023: Hospital for Special Surgery Announces Leadership Change
Jan 23, 2023: Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2022 Financial Results on February 14, 2023
Jan 16, 2023: TheraDiag Reports 2022 Revenue of €12.2 Million, up 9.7%
Jan 13, 2023: HSS Florida Continues to Grow With Appointment of Tara M. McCoy As CEO
Jan 06, 2023: Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023